Timothy A. Yap, James L. Gulley, Manish R. Sharma, Patricia LoRusso, Chris N. Barnes, Martin Decaris, Jenny Carolina Amaya Amaya. "Cohort expansion of a phase I study of PLN-101095, a first-in-class dual α
v
β
8
/α
v
β
1
integrin inhibitor, in combination with pembrolizumab in patients with advanced solid tumors refractory to immune checkpoint inhibitors (ICI).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.tps2690